Skip to content

Author

S. Samargandy

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Age and tumor size interact to increase the risk of incomplete response to therapy in differentiated thyroid carcinoma.

BACKGROUND This study evaluates whether age modifies the association between tumor size and the risk of incomplete response to therapy (IRT) in patients with differentiated thyroid cancer (DTC). METHODS A retrospective cohort study that included patients with DTC who underwent thyroidectomy from 2018 to 2022. Clinica...

S. Samargandy, Saad Samargandy · 0 citations
Open access Oct 2026

Comparison and Calibration of the 2025 and 2015 ATA Recurrence-Risk Classifications in Differentiated Thyroid Cancer

The 2025 American Thyroid Association (ATA) guidelines maintained the low- and high-risk categories and subdivided the intermediate-risk category of differentiated thyroid cancer (DTC) into low-intermediate and intermediate-high tiers. To determine whether observed rates of structural disease match the ris...

A. Alzahrani, Eman Albasri, A. Alkhamis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.